FDA CADAVERIC BLOOD SAMPLE STUDY RESULTS SHOW HIV TEST PERFORMANCE VARIABILITY
This article was originally published in The Gray Sheet
Executive Summary
FDA CADAVERIC BLOOD SAMPLE STUDY RESULTS SHOW HIV TEST PERFORMANCE VARIABILITY among the eight HIV antibody tests currently on the market, according to preliminary results from an agency study. The results were presented by Martin Ruta, a senior staff fellow in the Center for Biologics Evaluation and Research's Office of Blood Research and Review, at a June 20 public workshop on human tissue intended for transplantation.
You may also be interested in...
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.